🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Discordant Antigenic Properties of Soluble and Virion SARS-CoV-2 Spike Proteins

Viruses(2024)10.3390/v16030407Source: DataRank Database

Discordant Antigenic Properties of Soluble and Virion SARS-CoV-2 Spike Proteins is a research paper published in Viruses (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (18 grants)Impact (FWCI 0.61)OA: goldTopics (53)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Souradip Dasgupta ORCID,Mohammad M. Sajadi,Greg A. Snyder ORCID,Anthony L. DeVico,Krishanu Ray ORCID

Live enrichment

PubMed:38543772 PMC:PMC10974403 OpenAlex:https://openalex.org/W4392513332

National Institute of Allergy and Infectious Diseases of the National Institutes of Health

Grant: R01-AI150447

National Institute of Allergy and Infectious Diseases of the National Institutes of Health

Grant: R01-AI172487

National Institute of Allergy and Infectious Diseases of the National Institutes of Health

Grant: R61-AI176561

National Institute of Allergy and Infectious Diseases of the National Institutes of Health

Grant: R01-AI147870

National Institute of Allergy and Infectious Diseases of the National Institutes of Health

Grant: I01BX005469

National Institute of Allergy and Infectious Diseases of the National Institutes of Health

Grant: R01-GM129325

NIAID NIH HHS

Grant: R01 AI150447

NIH HHS

Grant: R01-AI150447 (KR), R01-AI172487 (KR), and R01-AI147870 (MMS)

NIAID NIH HHS

Grant: R61 AI176561

NIGMS NIH HHS

Grant: R01 GM129325

NIAID NIH HHS

Grant: R01 AI147870

NIAID NIH HHS

Grant: R01 AI172487

National Institutes of Health

Grant: 8R01AI150447-05

Conformational Dynamics of HIV Envelope by Single Molecule Spectroscopy

National Institutes of Health

Grant: 5R01AI147870-04

Engineering of pan-neutralizing anti-HIV envelope antibodies

National Institutes of Health

Grant: 5R61AI176561-03

Detection Assays for Virion Susceptibility to HIV Broadly Neutralizing Antibodies in Plasma and Culture Fluids

National Institutes of Health

Grant: 5R01AI172487-03

Broadly neutralizing antibody combinations with single virions in HIV+ plasma

National Institutes of Health

Grant: 1I01BX005469-01

COVID-19: Elucidating monoclonal and polyclonal seroantibody responses to the COVID-19 viral envelope

National Institutes of Health

Grant: 5R01GM129325-08

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling

FWCI

0.61

Citation Percentile

0.6%

Citation Trend

2025

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4915/16/3/407/pdf?version=1709774827

publisherhttps://www.mdpi.com/1999-4915/16/3/407/pdf?version=1709774827

publisherhttps://www.mdpi.com/1999-4915/16/3/407/pdf

journalhttps://doi.org/10.3390/v16030407

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38543772

Fields of Study

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesMonoclonal and Polyclonal Antibodies Research0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

COVID-19SARS-CoV-2Antibodies, MonoclonalAntibodies, ViralHumansVirionHIV AntibodiesHIV-1Antibodies, NeutralizingPandemicsSpike Glycoprotein, Coronavirus

Keywords

Monoclonal antibodyGlycanVirologyAntibodyAntigenChemistryNeutralizationNeutralizing antibodyViral entryBinding siteBiologyVirusBiochemistryGlycoproteinViral replicationGeneticsAntigenicityFluorescence Correlation SpectroscopyIn Vitro Binding AssaySars-cov-2 SpikeAnti-hiv Glycan MabsCovi-mabsSARS-CoV-2VirionCOVID-19Antibodies, MonoclonalHIV AntibodiesAntibodies, ViralMicrobiologyAntibodies, NeutralizingQR1-502ArticleSpike Glycoprotein, CoronavirusHIV-1HumansPandemics

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being